May 2020
Volume 15 Issue 5 |
|
|
|
|
Features
Human cells form the source material for cell therapies and they require a variety of assays to detect bacterial, fungal, and viral contaminants.
/ read more /
Conventional cleaning methods can risk product loss of biologics, prompting biopharmaceutical manufacturers to seek alternative criteria to validate cleaning processes.
/ read more /
|
|
|
Subscribe
Subscribers can enjoy each full issue of Pharmaceutical Technology in print or via the PharmTech app.
subscription offers |
 |
|
advertisement |
Exclusive Interview from AAPS:
Advancements in lipid-based delivery systems
/
View now. /
Sponsored by: Abitec |
|
|
advertisement |
Exclusive Interview from AAPS:
A Comprehensive Analysis Into Disintegration Mechanisms
/
View now. /
Sponsored by: JRS Pharma |
|
|
|
|
|
News
The lab is expected to open in April 2020 and will increase the company’s capacity for diagnostic testing of rare genetic diseases along with its COVID-19 capabilities.
/ read more /
A comprehensive turnkey system based on LabVantage’s laboratory information management system platform allows laboratories to implement COVID-19 biobanking, testing, and research.
/ read more /
The company has expanded capabilities for aggregate analytics to include dynamic light scattering.
/ read more /
|
|
|
|
New Technology
The spray dryer can be disassembled for autoclave sterilization and works to produce small-scale samples with minimum product loss.
/ read more /
Hosted by the International Forum Design, the event receives more than 6000 entries from 70 countries worldwide.
/ read more /
|
The new printers contain integrated PTLab software and can print directly onto slides and cassettes, eliminating handwritten mistakes and expensive labels.
/ read more /
Solentim and ATUM will bundle together the Leap-In Transposase platform with the VIPS single cell cloning instrument for cell line development.
/ read more /
|
WEBCASTS
Practical Considerations for Bringing Drug Candidates to Phase I Clinical Trial
Wednesday, May 27, 2020 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST
Ensuring Integrity of Drug Formulation from Development to QC Thursday, May 21, 2020 at 10am EDT | 9am CDT | 3pm BST | 4pm CEST
Analysis of Genotoxic Nitrosamine Impurities in Pharmaceutical Products under GMP Conditions using High-Resolution Accurate Mass (HRAM) Mass Spectrometry Wednesday, May 13, 2020 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST
Bulletproof your Supply Chain: Hope for the Best, Prepare for the Worst Monday, May 18, 2020 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST
Through Container Verification of Pharmaceutical Raw Materials with the New Agilent Vaya Handheld Raman System Europe Broadcast: Thursday, May 14, 2020 at 9am EDT | 2pm BST | 3pm CEST
US Broadcast: Thursday, May 14, 2020 at 2pm EDT | 1pm CDT | 11am PDT
Asia Pacific Broadcast: Friday, May 15, 2020 at 8:30am IST | 11am CST | 12pm JST | 1pm AEST
When Drug Meets Device: How to Assess Compatibility Tuesday, May 19, 2020 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST
|
|
|
| |